# FIBROGEN INC: Form D filing

FIBROGEN INC, a pharmaceuticals company in San Francisco, CA, filed a Form D with the SEC in 2014. The latest, on December 10, 2014, reports $20 million sold of a $20 million offering to 1 investor.

Find out what FIBROGEN INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20FIBROGEN%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=FIBROGEN%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ffibrogen-inc-921299)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20FIBROGEN%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=FIBROGEN%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ffibrogen-inc-921299)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 409 ILLINOIS STREET, San Francisco, CA, 94158
- Phone: (415) 978-1200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 921299

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 10, 2014 | New notice | $20,000,000 | $20,000,000 | $0 | 1 | Nov 19, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/921299/000128864914000010/0001288649-14-000010-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Frank H. Valone | Executive Officer |  |
| Thomas F. Kearns | Director |  |
| K. Peony H. Yu | Executive Officer |  |
| Jorma Pedro Routti | Director |  |
| Miguel F. Madero | Director |  |
| Rory B. Riggs | Director |  |
| Toshinari N. Tamura | Director |  |
| Kalevi F. Kurkijarvi | Director |  |
| Julian N. Stern | Director |  |
| Thomas B. Neff | Executive Officer, Director |  |
| James A. Schoeneck | Director |  |
| Pat B. Cotroneo | Executive Officer |  |
| Roberto Pedro Rosenkranz | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Dec 8, 2014](https://specstream.ai/data/form-d/week/2014-12-08) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what FIBROGEN INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).